World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03491163
Date of registration: 29/03/2018
Prospective Registration: Yes
Primary sponsor: Tadas Cesnaitis
Public title: Evaluation of Damaging Factors to Endothelial Glycocalyx During Heart Surgery Pilot Study
Scientific title: Evaluation of Damaging Factors to Endothelial Glycocalyx During On-pump Coronary Artery Bypass Surgery
Date of first enrolment: March 29, 2018
Target sample size: 150
Recruitment status: Unknown status
URL:  https://clinicaltrials.gov/show/NCT03491163
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Lithuania
Contacts
Name:     Tadas Cesnaitis
Address: 
Telephone: +37037326171
Email: tadas.cesnaitis@lsmuni.lt
Affiliation: 
Name:     Tadas Cesnaitis, MD
Address: 
Telephone: +37037326171
Email: tadas.cesnaitis@lsmuni.lt
Affiliation: 
Name:     Edmundas Sirvinskas, Prof
Address: 
Telephone:
Email:
Affiliation:  Professor at Lithuanian University of Health Sciences
Key inclusion & exclusion criteria

Inclusion Criteria:

- Elective on-pump coronary artery bypass surgery needed.

- Normal heart function at the time of operation.

- Patients without infections.

- Patients who signed study informed consent form

Exclusion Criteria:

- Life saving operation.

- Renal or hepatic dysfunction.

- Off-pump heart operation.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Heart; Surgery, Heart, Functional Disturbance as Result
Intervention(s)
Diagnostic Test: Syndecan-1 concentration evaluation
Primary Outcome(s)
Changes of syndecan-1 concentration during surgery and postoperative period. [Time Frame: 2 years]
The correlation of inflammatory status with glycocalyx damage. [Time Frame: 2 years]
Assess the risk of early postoperative complications and find possible correlation to syndecan-1 concentration changes. [Time Frame: 2 years]
Glycocalyx damage to patients with diabetes vs non-diabetes during heart surgery. [Time Frame: 2 years]
The evaluation of aortic clamping and on-pump duration on endothelial glycocalyx damage using syndecan-1 concentration measure. [Time Frame: 2 years]
Secondary Outcome(s)
Secondary ID(s)
ENDOTEL SYNDECAN-1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history